Drug Type Non-recombinant coagulation factor |
Synonyms Cross Eight Mc, クロスエイト MC |
Target |
Action stimulants |
Mechanism F10 stimulants(Coagulation factor X stimulants), Coagulation factor VIII replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (12 Mar 2013), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hemophilia A | Japan | 12 Mar 2013 |
Phase 2 | HER2-negative breast cancer First line | Maintenance | 15 | (fcuzlogfuh) = qnekbpegvu usuuhuzkjh (gnljyjzhic, 34.9 - 90.1) View more | - | 20 May 2011 |